How you prepare your morning cup of joe could be linked to an eye disease that affects nearly 20 million Americans.

Researchers in a new study learned that consuming this specific type of coffee may substantially increase a person’s risk of ...

These are exciting times for biotech business Complement Therapeutics, which stands on the cusp of an important milestone in ...

Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the ...

Approximately 200 million people globally live with age-related macular degeneration (AMD), with the majority affected by its ...

Alcon to Acquire LumiThera and its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD) ...

Older people with diabetes who do not keep blood sugar levels low are three times more likely to develop eye disease compared ...

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which ...

Alcon AG plans to acquire Lumithera Inc., adding its photobiomodulation (PBM) device designed to treat early and intermediate ...

In this video from Clinical Trials at the Summit, Carl D. Regillo, MD, FACS, discusses the use of tyrosine kinase inhibitors for wet age-related macular degeneration and diabetic retinopathy with ...